AdvertisementGilead Declines 'Rare Disease' Status For Experimental Coronavirus DrugMarch 25, 2020Sydney LupkinfacebookEmailAfter the Food and Drug Administration granted Gilead Sciences orphan drug status for its experimental drug remdesivir on Tuesday, Gilead asked that the agency rescind that status Wednesday. (Bloomberg via Getty Images)
